Back
Cognition Therapeutics Stock Price Chart

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
12
CGTX
Cognition Therapeutics
Last Price:
$0.42
Seasonality Move:
1.72%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight selling pressure.
Cognition Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.45 | Sell |
20-day SMA: | 0.44 | Sell |
50-day SMA: | 0.56 | Sell |
200-day SMA: | 0.79 | Sell |
8-day EMA: | 0.44 | Sell |
20-day EMA: | 0.46 | Sell |
50-day EMA: | 0.52 | Sell |
200-day EMA: | 0.81 | Sell |
Cognition Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 38.37 | Sell |
Chaikin Money Flow: | -322444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.42 - 0.48) | Sell |
Bollinger Bands (100): | (0.43 - 0.69) | Sell |
Cognition Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.42 while CGTX 8-day simple moving average is 0.45, which is a Sell signal.
-
The stock price of CGTX is 0.42 while Cognition Therapeutics 20-day SMA is 0.44, which makes it a Sell.
-
Cognition Therapeutics 50-day simple moving average is 0.56 while CGTX share price is 0.42, making it a Sell technically.
-
CGTX stock price is 0.42 and Cognition Therapeutics 200-day simple moving average is 0.79, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
12
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.42. The Score for CGTX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
25.8M
Price in USD:
0.42
Share Volume:
431.7K
Cognition Therapeutics 52-Week Range
52-Week High:
2.95
52-Week Low:
0.34
Sell
12
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.42 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.42 while CGTX 8-day exponential moving average is 0.44, which is a Sell signal.
-
The stock price of CGTX is 0.42 while Cognition Therapeutics 20-day EMA is 0.46, which makes it a Sell.
-
Cognition Therapeutics 50-day exponential moving average is 0.52 while CGTX share price is 0.42, making it a Sell technically.
-
CGTX stock price is 0.42 and Cognition Therapeutics 200-day simple moving average is 0.81, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $0.39 per share, and an increase next year of $0.14 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 38.37, which suggest Cognition Therapeutics is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.42 - 0.48), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.43 - 0.69), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.